USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Recent Innovations in Precision Medicine for Immunological, Inflammatory and Oncological Indications
15-Nov-2024
Global
Technology Research
D759-00-4A-00-00
HC_2025_33837
$950.00
Special Price $807.50 save 15 %
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights recent advances in targeted therapies for cancer, immunological and inflammatory diseases. The research also covers technological developments across vaccines, neuroprotective medicines, cell therapies, monoclonal antibody and oncolytic virus platforms.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Keywords: Precision Medicine, Immunological Diseases, Stem Cells, iPSC, Neurological Diseases, Neuroprotective Therapies, Vaccines, Respiratory Diseases, Monoclonal Antibody, Inflammatory Diseases, Regenerative Macrophage Therapy, TCR-T Therapy, Cancer, Oncolytic HSV-1, Intrahepatic Cholangiocarcinoma, Targeted T-cell Antigen Coupler, Solid Cancer, Machine Learning, Drug Discovery
Alumis, the United States
GC Therapeutics GCTx, the United States
Nura Bio, the United States
Vicebio, the United States
Triveni Bio, the United States
Resolution Therapeutics, the United Kingdom
Medigene, Germany
Virogin Biotech, the United States
Triumvira, the United States
Kimia Therapeutics, the United States
Speak directly with our analytics experts for tailored recommendations.
Recent related In Vitro Diagnostics (IVD) research
27 Aug 2026 | Global | Frost Radar
Frost Radar: AI-Powered Molecular Diagnostics, 2026
AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...
25 Aug 2026 | Global | Technology Research
Breakthrough Innovations in Point-of-Care Diagnostics
This research analyzes how point-of-care (PoC) diagnostics is evolving from simple tests to decentralized, connected, and clinically actionable testing platforms across hospitals, outpatient settings, homes, and pharmacies.
The study assesses key technology shifts, including rapid molecular t...
21 Aug 2026 | Global | Technology Research
Innovations and Growth Opportunities in AI-Driven Biomanufacturing, Advanced Cell and Gene Therapies, and Precision Immunotherapy
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease...
07 Aug 2026 | Global | Customer Research
Laboratory Product Purchasing Trends, United States and Europe, 2025–2026
Qualified respondents to this Frost & Sullivan survey were invited to participate in an online survey examining their laboratory’s product purchasing process in 2025 and expectations for 2026. Frost & Sullivan has conducted similar studies among the same target respondent groups since 2012. The su...
21 Jul 2026 | Global | Market Research
Point-of-Care Testing Market, Global, 2024–2031
The global POCT market is rapidly evolving from standalone rapid diagnostics to connected, AI-enabled clinical intelligence ecosystems that support decentralized healthcare delivery. Growth is driven by the increasing demand for faster clinical decision-making, early disease detection, personalized ...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Keywords: Precision Medicine, Immunological Diseases, Stem Cells, iPSC, Neurological Diseases, Neuroprotective Therapies, Vaccines, Respiratory Diseases, Monoclonal Antibody, Inflammatory Diseases, Regenerative Macrophage Therapy, TCR-T Therapy, Cancer, Oncolytic HSV-1, Intrahepatic Cholangiocarcinoma, Targeted T-cell Antigen Coupler, Solid Cancer, Machine Learning, Drug Discovery
| Deliverable Type | Technology Research |
|---|---|
| Industries | Healthcare |
| No Index | No |
| Is Prebook | No |
| Podcast | No |
| WIP Number | D759-00-4A-00-00 |